Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk
- PMID: 19908237
- PMCID: PMC4433472
- DOI: 10.1002/pros.21067
Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk
Abstract
Background: Prostate cancer (PCa) incidence and mortality are disproportionately high among African-American (AA) men. Its detection and perhaps its disparities could be improved through the identification of genetic susceptibility biomarkers within essential biological pathways. Interactions among highly variant genes, central to angiogenesis, may modulate susceptibility for prostate cancer, as previous demonstrated. This study evaluates the interplay among three highly variant genes (i.e., IL-10, TGFbetaR-1, VEGF), their receptors and their influence on PCa within a case-control study consisting of an under-served population.
Methods: This study evaluated single gene and joint modifying effects on PCa risk in a case-control study comprised of 859 AA men (193 cases and 666 controls) using TaqMan qPCR. Interaction among polymorphic IL-10, TGFbetaR-1 and VEGF was analyzed using conventional logistic regression analysis (LR) models, multi-dimensionality reduction (MDR) and interaction entropy graphs. Symbolic modeling allowed validation of gene-gene interaction findings identified by MDR.
Results: No significant single gene effects were demonstrated in relation to PCa risk. However, carriers of the VEGF 2482T allele had a threefold increase in the risk of developing aggressive PCa. The presence of VEGF 2482T combined with VEGFR IVS6 + 54 loci were highly significant for the risk of PCa based on MDR and symbolic modeling analyses. These findings were substantiated by 1,000-fold cross validation permutation testing (P = 0.04), respectively.
Conclusion: These findings suggest the inheritance of VEGF and VEGFR IVS6 + 54 sequence variants may jointly modify PCa susceptibility through their influence on angiogenesis. Larger sub-population studies are needed to validate these findings and evaluate whether the VEGF-VEGR axis may serve as predictors of disease prognosis and ultimately clinical response to available treatment strategies.
Prostate 70: 341-352, 2010. (c) 2009 Wiley-Liss, Inc.
Figures

Similar articles
-
Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study.BMC Cancer. 2009 Nov 16;9:397. doi: 10.1186/1471-2407-9-397. BMC Cancer. 2009. PMID: 19917083 Free PMC article.
-
Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer.BMC Med Genomics. 2012 Apr 30;5:11. doi: 10.1186/1755-8794-5-11. BMC Med Genomics. 2012. PMID: 22546513 Free PMC article.
-
Positive association between vascular endothelial growth factor (VEGF) -2578 C/A variant and prostate cancer.Cancer Biomark. 2013;13(4):235-41. doi: 10.3233/CBM-130348. Cancer Biomark. 2013. PMID: 24240584
-
Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects.Gene. 2018 Dec 30;679:241-252. doi: 10.1016/j.gene.2018.09.005. Epub 2018 Sep 6. Gene. 2018. PMID: 30195633 Review.
-
Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.Gene. 2019 May 25;698:186-197. doi: 10.1016/j.gene.2019.02.070. Epub 2019 Mar 5. Gene. 2019. PMID: 30849545
Cited by
-
Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.Oncotarget. 2017 Jul 25;8(30):50034-50050. doi: 10.18632/oncotarget.17293. Oncotarget. 2017. PMID: 28489583 Free PMC article.
-
Racial and Ethnic Health Disparities in Incarcerated Populations.J Health Dispar Res Pract. 2012;5(2):92-100. J Health Dispar Res Pract. 2012. PMID: 23338674 Free PMC article.
-
Common polymorphisms in angiogenesis.Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a006510. doi: 10.1101/cshperspect.a006510. Cold Spring Harb Perspect Med. 2012. PMID: 23125197 Free PMC article. Review.
-
Association between HIF1A rs11549465 polymorphism and risk of prostate cancer: a meta-analysis.Oncotarget. 2017 Jul 4;8(27):44910-44916. doi: 10.18632/oncotarget.16489. Oncotarget. 2017. PMID: 28415653 Free PMC article. Review.
-
Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects.Med Oncol. 2011 Dec;28(4):1169-75. doi: 10.1007/s12032-010-9613-1. Epub 2010 Jul 16. Med Oncol. 2011. PMID: 20635170
References
-
- Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78–85. - PubMed
-
- Michaud DS, Daugherty SE, Berndt SI, Platz EA, Yeager M, Crawford ED, Hsing A, Huang WY, Hayes RB. Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res. 2006;66:4525–4530. - PubMed
-
- Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet. 2001;27:172–180. - PubMed
-
- Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S, Gronberg H, Emanuelsson M, Damber JE, Bergh A, Jonsson BA, Smith J, Bailey-Wilson J, Carpten J, Stephan D, Gillanders E, Amundson I, Kainu T, Freas-Lutz D, Baffoe-Bonnie A, Van AA, Sood R, Collins F, Brownstein M, Trent J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet. 1998;20:175–179. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical